FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 343:1086-1094 October 12, 2000 Number 15 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

There are more than 2 million women in the United States alone who are living with a history of breast cancer.^1,2 Screening programs have increased the number of women in whom invasive or noninvasive breast cancer has been diagnosed, and earlier detection and better treatment have led to improved prognosis. Thus, although the average U.S. woman has a 12.6 percent lifetime risk of breast cancer — a percentage that has risen in recent years — her risk of death from breast cancer has remained constant at 3.6 percent. Most women in whom breast cancer is diagnosed do not die of . . . [Full Text of this Article]

Medical Evaluation

Local Complications of Therapy for Breast Cancer

Late Complications of Chemotherapy

Gynecologic and Reproductive Implications of Therapy

Amenorrhea Related to Chemotherapy

Effects of Tamoxifen on Gynecologic Function and Fertility

Pregnancy and Lactation

Hormone-Replacement Therapy

Osteoporosis and Cardiovascular Risk Factors

Management of Menopausal Symptoms

Psychosocial Issues

Changes in Lifestyle

Source Information

From the Breast Oncology Center, Department of Adult Oncology, Dana–Farber Cancer Institute; the Department of Medicine, Brigham and Women's Hospital; and Harvard Medical School — all in Boston.

Address reprint requests to Dr. Burstein at the Breast Oncology Center, Dana–Farber Cancer Institute, 44 Binney St., Boston, MA 02115.

References

This article has been cited by other articles:

• Kenne Sarenmalm, E., Thoren-Jonsson, A.-L., Gaston-Johansson, F., Ohlen, J. (2009). Making Sense of Living Under the Shadow of Death: Adjusting to a Recurrent Breast Cancer Illness. Qual Health Res 19: 1116-1130 [Abstract]  
• Jeruss, J. S., Woodruff, T. K. (2009). Preservation of Fertility in Patients with Cancer. NEJM 360: 902-911 [Full Text]  
• Mao, J. J., Bowman, M. A., Stricker, C. T., DeMichele, A., Jacobs, L., Chan, D., Armstrong, K. (2009). Delivery of Survivorship Care by Primary Care Physicians: The Perspective of Breast Cancer Patients. JCO 27: 933-938 [Abstract] [Full Text]  
• Sabatino, S. A., Coates, R. J., Uhler, R. J., Pollack, L. A., Alley, L. G., Zauderer, L. J. (2007). Provider Counseling About Health Behaviors Among Cancer Survivors in the United States. JCO 25: 2100-2106 [Abstract] [Full Text]  
• Leining, M., Gelber, S, Rosenberg, R, Przypyszny, M, Winer, E., Partridge, A. (2006). Menopausal-type symptoms in young breast cancer survivors. Ann Oncol 17: 1777-1782 [Abstract] [Full Text]  
• Lee, S. J., Schover, L. R., Partridge, A. H., Patrizio, P., Wallace, W. H., Hagerty, K., Beck, L. N., Brennan, L. V., Oktay, K. (2006). American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients. JCO 24: 2917-2931 [Abstract] [Full Text]  
• Grunfeld, E., Levine, M. N., Julian, J. A., Coyle, D., Szechtman, B., Mirsky, D., Verma, S., Dent, S., Sawka, C., Pritchard, K. I., Ginsburg, D., Wood, M., Whelan, T. (2006). Randomized Trial of Long-Term Follow-Up for Early-Stage Breast Cancer: A Comparison of Family Physician Versus Specialist Care. JCO 24: 848-855 [Abstract] [Full Text]  
• Stanton, A. L., Ganz, P. A., Kwan, L., Meyerowitz, B. E., Bower, J. E., Krupnick, J. L., Rowland, J. H., Leedham, B., Belin, T. R. (2005). Outcomes From the Moving Beyond Cancer Psychoeducational, Randomized, Controlled Trial With Breast Cancer Patients. JCO 23: 6009-6018 [Abstract] [Full Text]  
• Thewes, B., Meiser, B., Taylor, A., Phillips, K.A., Pendlebury, S., Capp, A., Dalley, D., Goldstein, D., Baber, R., Friedlander, M.L. (2005). Fertility- and Menopause-Related Information Needs of Younger Women With a Diagnosis of Early Breast Cancer. JCO 23: 5155-5165 [Abstract] [Full Text]  
• Simon, B., Lee, S. J., Partridge, A. H., Runowicz, C. D. (2005). Preserving Fertility After Cancer. CA Cancer J Clin 55: 211-228 [Abstract] [Full Text]  
• Winer, E. P., Hudis, C., Burstein, H. J., Wolff, A. C., Pritchard, K. I., Ingle, J. N., Chlebowski, R. T., Gelber, R., Edge, S. B., Gralow, J., Cobleigh, M. A., Mamounas, E. P., Goldstein, L. J., Whelan, T. J., Powles, T. J., Bryant, J., Perkins, C., Perotti, J., Braun, S., Langer, A. S., Browman, G. P., Somerfield, M. R. (2005). American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Status Report 2004. JCO 23: 619-629 [Abstract] [Full Text]  
• Partridge, A. H., Gelber, S., Peppercorn, J., Sampson, E., Knudsen, K., Laufer, M., Rosenberg, R., Przypyszny, M., Rein, A., Winer, E. P. (2004). Web-Based Survey of Fertility Issues in Young Women With Breast Cancer. JCO 22: 4174-4183 [Abstract] [Full Text]  
• Lipscomb, J., Donaldson, M. S., Arora, N. K., Brown, M. L., Clauser, S. B., Potosky, A. L., Reeve, B. B., Rowland, J. H., Snyder, C. F., Taplin, S. H. (2004). Cancer Outcomes Research. J Natl Cancer Inst Monogr 2004: 178-197 [Full Text]  
• Tsao, A. S., Kim, E. S., Hong, W. K. (2004). Chemoprevention of Cancer. CA Cancer J Clin 54: 150-180 [Abstract] [Full Text]  
• Schroder, C.P., Timmer-Bosscha, H., Wijchman, J.G., de Leij, L.F.M.H., Hollema, H., Heineman, M.J., de Vries, E.G.E. (2004). An in vitro model for purging of tumour cells from ovarian tissue. Hum Reprod 19: 1069-1075 [Abstract] [Full Text]  
• Garman, K. S., Pieper, C. F., Seo, P., Cohen, H. J. (2003). Function in Elderly Cancer Survivors Depends on Comorbidities. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 58: M1119-1124 [Abstract] [Full Text]  
• McKelvey, K. D. Jr., Evans, J. P. (2003). Cancer Genetics in Primary Care. J. Nutr. 133: 3767S-3772 [Abstract] [Full Text]  
• Rock, E., DeMichele, A. (2003). Nutritional Approaches to Late Toxicities of Adjuvant Chemotherapy in Breast Cancer Survivors. J. Nutr. 133: 3785S-3793 [Abstract] [Full Text]  
• Kattlove, H., Winn, R. J. (2003). Ongoing Care of Patients After Primary Treatment for Their Cancer. CA Cancer J Clin 53: 172-196 [Abstract] [Full Text]  
• Earle, C. C., Burstein, H. J., Winer, E. P., Weeks, J. C. (2003). Quality of Non-Breast Cancer Health Maintenance Among Elderly Breast Cancer Survivors. JCO 21: 1447-1451 [Abstract] [Full Text]  
• Winer, E. P., Hudis, C., Burstein, H. J., Chlebowski, R. T., Ingle, J. N., Edge, S. B., Mamounas, E. P., Gralow, J., Goldstein, L. J., Pritchard, K. I., Braun, S., Cobleigh, M. A., Langer, A. S., Perotti, J., Powles, T. J., Whelan, T. J., Browman, G. P. (2002). American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors as Adjuvant Therapy for Women With Hormone Receptor-Positive Breast Cancer: Status Report 2002. JCO 20: 3317-3327 [Abstract] [Full Text]  
• Scheuer, L., Kauff, N., Robson, M., Kelly, B., Barakat, R., Satagopan, J., Ellis, N., Hensley, M., Boyd, J., Borgen, P., Norton, L., Offit, K. (2002). Outcome of Preventive Surgery and Screening for Breast and Ovarian Cancer in BRCA Mutation Carriers. JCO 20: 1260-1268 [Abstract] [Full Text]  
• Ganz, P. A., Desmond, K. A., Leedham, B., Rowland, J. H., Meyerowitz, B. E., Belin, T. R. (2002). Quality of Life in Long-Term, Disease-Free Survivors of Breast Cancer: a Follow-up Study. JNCI J Natl Cancer Inst 94: 39-49 [Abstract] [Full Text]  
• National Institutes of Health Consensus Developmen, (2001). National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000. J Natl Cancer Inst Monogr 2001: 5-15 [Abstract] [Full Text]  
• Partridge, A. H., Burstein, H. J., Winer, E. P. (2001). Side Effects of Chemotherapy and Combined Chemohormonal Therapy in Women With Early-Stage Breast Cancer. J Natl Cancer Inst Monogr 2001: 135-142 [Abstract] [Full Text]  
• (2001). National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000. JNCI J Natl Cancer Inst 93: 979-989 [Abstract] [Full Text]  
• Potter, J., Ship, A. N., Love, R. R., Burstein, H. J., Winer, E. P. (2001). Survivors of Breast Cancer. NEJM 344: 309-310 [Full Text]